City

London (1)

Vienna (1)

Condition

Uveitis Related Cystoid Macular Edema (3)

Cystoid Macular Edema, Postoperative (1)

Steroid-induced Glaucoma - Borderline (1)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Medical University of Vienna (1)

Moorfields Eye Hospital NHS Foundation Trust (1)

Quan Dong Nguyen (1)

Collaborator

Global Ophthalmic Research Center (GORC) (1)

Novartis (1)

Oculis (1)

Intervention

ocs-01 (1)

ranibizumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

uveitis related cystoid macular edema

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative Trial (OCS-01)

Not yet recruiting

Uveitis Related Cystoid Macular Edema
Cystoid Macular Edema, Postoperative

OCS-01

(no location specified)

Nov 1, 2022

Uveitis Related Cystoid Macular Edema, Steroid-induced Glaucoma - Borderline Trial in London (Ranibizumab)

Completed

Uveitis Related Cystoid Macular Edema
Steroid-induced Glaucoma - Borderline

Ranibizumab

London, United Kingdom

Moorfields Eye Hospital NHSFT Research and Treatment Centre

Mar 25, 2019

Functional and Morphologic Aspects of Intravitreal Triamcinolone

Completed

Uveitis Related Cystoid Macular Edema

Vienna, Austria

Medical University Vienna

Dec 24, 2011